Leaders of the Maryland legislature reacted with alarm to a report that nearly a dozen members of the University of Maryland Medical System’s board of directors have lucrative business deals with the institution.
Many of the deals run into six figures, and a lawmaker who has introduced conflict of interest legislation said there is no evidence that the contracts were competitively bid.
“Board members are supposed to be motivated by a desire to serve the interests of the patients of Baltimore City and the state,” Sen. Jill P. Carter (D-Baltimore) told the Senate Finance Committee. “Unfortunately, this does not appear to be the case.”
Carter’s bill, Senate Bill 619, would prohibit board members from having a financial interest in a business that has, or is negotiating, a contract with the system. It would also bar a member of the UMMS board from “intentionally using the prestige of office for private gain or the gain of another.”
Her proposal had its hearing one day after The Baltimore Sun reported that nine of the medical system’s 30 board members — including Baltimore Mayor Catherine Pugh — have financial arrangements with UMMS
Read Full article on Maryland Matters